India rejects JJ plea to extend patent on key Tuberculosis drug, drop in prices expected
The drugs work by targeting the adenosine triphosphate (ATP) synthase enzyme of the TB mycobacteria.
Latest News from Moneycontrol.com
How Privileged Access Tools Reduce Cybersecurity Risks











